<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18260">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01836510</url>
  </required_header>
  <id_info>
    <org_study_id>TA100</org_study_id>
    <nct_id>NCT01836510</nct_id>
  </id_info>
  <brief_title>Selection of Potential Predictors of Worsening Heart Failure</brief_title>
  <acronym>BioDetectHFIV</acronym>
  <official_title>Selection of Potential Predictors of Worsening Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <authority>Italy: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicentre study with the objective to correlate heart failure hospitalizations and deaths
      with Home Monitoring data in ICD/CRT-D recipients, in order to identify the combination of
      Home Monitoring data with the greatest sensitivity and specificity in predicting Heart
      Failure events.

      All data are prospectively collected.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Home Monitoring remotely provides continuous trends of potential HF-related variables with a
      sampling interval of 24 hours. Although the predictive value of individual variables  may
      be  limited,  a  proper  combination  of  more  variables  and  their  24-hour  sampling
      may  allow  developing  a  HM  diagnostic  algorithm  to  accurately predict HF worsening
      within given time windows. The objective of this Study is to  select  the  predictive
      variables which are most likely to be effectively included in a future algorithm.

      This is a multicentre, exploratory Study with the objective to  prospectively collect follow
      -up  and  Home Monitoring data from a population of  subjects  with indication for ICD
      and/or CRT-D implantation, to document HF hospitalizations and deaths and to correlate these
      events with HM data to identify the combination of HM data with the greatest sensitivity and
      specificity in predicting HF events.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>First Hospitalization for worsening Heart Failure (HF)</measure>
    <time_frame>Participants will be followed for the duration of follow-up, an expected average of 2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hospitalization is defined as a non-elective hospital admission for medical or surgical therapy that results in at least one overnight stay.
Hospitalization for worsening HF is defined as a hospitalization fulfilling the following criteria:
It was triggered by increased symptom(s) and sign(s) OR objective evidence of worsening HF (LVEF, ECG, or other instrumental evidences);
It required administration or augmentation of intravenous or oral HF medication;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>A composite of death for worsening heart failure, hospitalizations for worsening HF and acute interventions for worsening HF.</measure>
    <time_frame>Participants will be followed for the duration of follow-up, an expected average of 2 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">650</enrollment>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Population of subjects with an indication for ICD and/or CRT-D implantation according to
        current guidelines
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Left Ventricular Ejection Fraction (LVEF) ≤ 35%

          -  NYHA Class II or III Heart Failure

          -  Men and women 18 years of age or older

          -  Understand the nature of the procedure

          -  Give written informed consent

        Exclusion Criteria:

          -  No indication or contraindication for ICD or CRT-D therapy

          -  Permanent AF

          -  NYHA Class IV Heart Failure

          -  Subjects with irreversible brain damage from preexisting cerebral disease;

          -  Subjects with acutely decompensated heart failure

          -  Expected heart transplantation within next six months or planned cardiac surgery
             within next 3 months

          -  Have a life expectancy of less than six months

          -  Presence of any disease, other than the subject's cardiac disease associated with a
             reduced likelihood of survival for the duration of the trial, (e.g. cancer)

          -  Unstable geographical residence (unable to anticipate to be resident in the area of
             the referring participating centre during the study period) and/or GSM-free residence

          -  Subjects who were not been implanted with ICD or CRT-D devices compatible with HM
             transmissions

          -  Age &lt;18 years

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luigi Padeletti, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>A.O.U Careggi, Florence</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicola Rovai</last_name>
    <phone>+39 334 63 79 010</phone>
    <email>nicola.rovai@biotronik.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alessio Gargaro</last_name>
    <phone>+39 335 75 00 241</phone>
    <email>alessio.gargaro@biotronik.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cliniche Humanitas Gavazzeni</name>
      <address>
        <city>Bergamo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giuosuè Mascioli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spedali Civili</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Antonio Curnis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Di Summa Hospital</name>
      <address>
        <city>Brindisi</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Carmela Scianaro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Francesco Ferrari Hospital</name>
      <address>
        <city>Casarano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Donato Melissano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sant'Anna Hospital</name>
      <address>
        <city>Como</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gianluca Botto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S. Croce Hospital</name>
      <address>
        <city>Cuneo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Antonello Vado</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U. Careggi</name>
      <address>
        <city>Florence</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Luigi Padeletti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mater Salutis Hospital</name>
      <address>
        <city>Legnago</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gabriele Zanotto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A. O. Monaldi</name>
      <address>
        <city>Naples</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Antonio D'Onofrio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile</name>
      <address>
        <city>Piacenza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giovanni Quinto Villani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S. Maria degli Angeli Hospital</name>
      <address>
        <city>Pordenone</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marco Brieda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Casilino</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Leonardo Calò</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Multimedica</name>
      <address>
        <city>Sesto San Giovanni</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Edoardo Gronda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santissima Annunziata Hospital</name>
      <address>
        <city>Taranto</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vitantonio Russo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S. Maria di Ca' Foncello Hospital</name>
      <address>
        <city>Treviso</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vittorio Calzolari</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U. Ospedali Riuniti</name>
      <address>
        <city>Trieste</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Massimo Zecchin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Circolo e Fondazione Macchi, O.U. Cardiology I</name>
      <address>
        <city>Varese</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fabrizio Caravati</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Circolo e Fondazione Macchi, O.U. Cardiology II</name>
      <address>
        <city>Varese</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paolo Bonfanti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guzzardi Hospital</name>
      <address>
        <city>Vittoria (RG)</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Vladimiro Lettica</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 17, 2013</lastchanged_date>
  <firstreceived_date>March 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Remote Monitoring</keyword>
  <keyword>Lung Edema</keyword>
  <keyword>Patient Monitoring</keyword>
  <keyword>Prediction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
